Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
OncoOne logo — The world’s leaders in oxMIF targeted therapies against the...

OncoOne

The world’s leaders in oxMIF targeted therapies against the macrophage migration inhibitory factor. www.OncoOne.com

Founded 2018 Austria Austria 12 employees Series A Total: $13.00M Biotechnology, Health and Wellness

General Information

Company Name OncoOne
Founded Year 2018
Location Austria Austria +1
Employees 12
Industries Biotechnology, Health and Wellness
Funding Stage Series A
Social

Get notified when OncoOne moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About OncoOne

OncoOne is a biotech start-up dedicated to developing innovative therapeutics to treat patients with solid tumors and inflammation. Founded in 2018 and headquartered in Austria, the company's focus is on oxMIF targeted therapies against the macrophage migration inhibitory factor. The company received a significant €13.00M Series A investment on 18 March 2020 from Austrian Research Promotion Agency and Austria Wirtschaftsservice (aws). OncoOne's commitment to addressing critical medical needs through cutting-edge biotechnology makes it a promising investment opportunity in the biotech industry. More information is available on their website www.OncoOne.com.

Taxonomy: biotech, therapeutics, solid tumors, inflammatory conditions, drug development, oncology research, pharmaceutical industry, innovative treatments, oncology, biotech start-up, fledgling firm

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 2
Investor Investor
18 Mar 2020

OncoOne Alternatives & Competitors

OncoOne vs
Microbiotica
Microbiotica United Kingdom

The microbiome is a new approach to medicine, offering potential for significant advancements. Micro...

Series Unknown
49 employees
Biotechnology, Health Care
OncoOne vs
Ionova Life Science
Ionova Life Science China

VC-backed clinical-stage biotech, translates basic biomedical discoveries into novel therapeutics, f...

Series Unknown
15 employees
Biotechnology, Health Care
OncoOne vs
siRNAgen Therapeutics
siRNAgen Therapeutics United States

Harnessing the SAMiRNA™ platform to revolutionize the treatment of immunology and CNS diseases

6 employees
Health Care

FAQ About OncoOne

The world’s leaders in oxMIF targeted therapies against the macrophage migration inhibitory factor. www.OncoOne.com
OncoOne was founded in 2018.
OncoOne is headquartered in Austria.
OncoOne operates in the following industries: Biotechnology, Health and Wellness.
OncoOne has approximately 12 employees.
OncoOne has completed 1 funding round, raising a total of $13.00M. The latest funding stage is Series A.
Top alternatives and competitors to OncoOne include Microbiotica , Ionova Life Science, siRNAgen Therapeutics, Topmunnity Therapeutics Limited, LumaBridge. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
OncoOne and Microbiotica are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors OncoOne and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes